首页 > 市场调查报告书 > 医疗设备

骨骼生长刺激器市场规模、份额及成长分析（按材质、应用、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1900614

骨骼生长刺激器市场规模、份额及成长分析（按材质、应用、最终用户和地区划分）－2026-2033年产业预测

Bone Growth Stimulators Market Size, Share, and Growth Analysis, By Material Type (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球骨骼生长刺激器市场规模预计在 2024 年达到 29.6 亿美元，从 2025 年的 31.3 亿美元增长到 2033 年的 48.3 亿美元，在预测期（2026-2033 年）内复合年增长率为 5.6%。

骨骼生长刺激剂作为一种辅助治疗方法，在促进癒合方面需求日益增长，尤其适用于难以自然癒合的骨折。全球骨折和运动伤害发病率的不断上升是推动该市场发展的主要因素。脊髓损伤也显着增加了对有效治疗方法的需求，每年影响众多患者。骨生长刺激技术和产品已被证明在包括整形外科、牙科和骨折修復在内的多个领域都具有很高的应用价值。骨关节炎和退化性疾病的高发生率进一步支撑了该市场的发展。此外，富血小板血浆（PRP）和骨形成蛋白（BMP）在治疗效果方面的进步预计将推动该领域未来的成长。

推动全球骨骼生长刺激器市场发展的因素

整形外科疾病（包括骨折、骨延迟癒合、骨不连和骨质疏鬆相关损伤）发生率的不断上升，是骨生长刺激器市场的主要驱动力。随着人口老化相关疾病和整形外科问题的日益增多，对有效治疗方法的需求也随之增长。医疗专业人员致力于应对这些普遍存在的患者照护挑战，因此，对促进骨骼癒合和再生的创新解决方案的需求不断增长，推动了骨生长刺激器技术的进步。预计这些刺激器的市场将显着扩大。

限制全球骨骼生长刺激器市场的因素

全球骨骼生长刺激器市场面临一些限制因素，主要与使用过程中存在的风险和副作用有关。虽然这些设备通常被认为是安全的，但仍可能引起皮肤刺激、过敏反应和治疗过程中的不适等问题。这些潜在的不良反应引起了患者和医疗保健提供者的担忧，可能导致他们不愿意采用这些技术。随着越来越多的人选择风险较低的替代疗法和治疗方法，这种担忧可能会阻碍市场成长，从而影响骨骼生长刺激器的整体市场需求和接受度。

全球骨骼生长刺激器市场趋势

全球骨生长刺激器市场正经历显着的变革，这主要得益于非侵入性治疗方法方案的拓展。患者和医疗专业人员越来越多地选择骨骼生长刺激器，它为脊椎融合手术和骨折等疾病提供了比传统手术更人性化的替代方案。这一趋势反映了人们对微创技术的广泛需求，这些技术能够促进癒合和康復，同时最大限度地降低风险和不适感。此外，技术的进步以及人们对这些设备益处的日益了解也促进了其广泛应用，骨生长刺激器正逐渐成为现代整形外科治疗的重要组成部分。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Orthofix Holdings, Inc.（USA）
Medtronic plc（Ireland）
Zimmer Biomet Holdings, Inc.（USA）
Stryker Corporation（USA）
Terumo Corporation（Japan）
Bioventus LLC（USA）
Igea SpA（Italy）
Ossatec AS（Norway）
Biotronik SE & Co. KG（Germany）
DJO Global, Inc.（USA）
EMS Physio Ltd.（UK）
Orthocell Ltd.（Australia）
Altis Biologics（South Africa）
ISTO Biologics（USA）
Regenlab SA（Switzerland）
Exactech, Inc.（USA）
Collagen Matrix, Inc.（USA）
ATEC, Inc.（USA）

结论与建议

简介目录

Product Code: SQMIG35A2314

Global Bone Growth Stimulators Market size was valued at USD 2.96 Billion in 2024 and is poised to grow from USD 3.13 Billion in 2025 to USD 4.83 Billion by 2033, growing at a CAGR of 5.6% during the forecast period (2026-2033).

The demand for bone growth stimulators is on the rise as they serve as a complementary therapy for enhancing the healing of fractures, particularly those resistant to natural recovery. The increasing incidence of bone fractures and sports injuries globally is a key driver of this market. Spinal cord injuries also contribute significantly to the need for effective treatment options, impacting numerous individuals yearly. Bone growth stimulation technologies and products are proving invaluable across various fields, including orthopedics, dentistry, and fracture repair. The market is further supported by the prevalence of osteoarthritis and degenerative bone diseases. Additionally, advancements in healing outcomes through the use of platelet-rich plasma and bone morphogenetic proteins are expected to propel future growth in this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bone Growth Stimulators market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bone Growth Stimulators Market Segments Analysis

Global Bone Growth Stimulators Market is segmented by Material Type, Application, End User and region. Based on Material Type, the market is segmented into Bone Growth Stimulation Devices, Bone Morphogenetic Proteins and Platelet-Rich Plasma. Based on Application, the market is segmented into Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries and Other Applications. Based on End User, the market is segmented into Hospitals and Ambulatory Surgical Centers, Home Care Settings and Academic and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bone Growth Stimulators Market

The increasing incidence of orthopedic disorders, including fractures, delayed unions, non-unions, and osteoporosis-related injuries, serves as a major catalyst for the bone growth stimulators market. With a larger segment of the population experiencing age-related conditions and related orthopedic issues, there is a corresponding surge in the need for effective treatment options. This growing demand for innovative solutions to enhance bone healing and regeneration is driving advancements in bone growth stimulators, as healthcare providers seek to address these prevalent challenges in patient care. Consequently, the market for these stimulators is poised for significant expansion.

Restraints in the Global Bone Growth Stimulators Market

The Global Bone Growth Stimulators market faces certain restraints primarily due to the associated risks and side effects linked to their use. Although these devices are predominantly deemed safe, they can cause issues such as skin irritation, allergic reactions, and discomfort during treatment. Such potential adverse effects may raise concerns among patients and healthcare providers alike, leading to hesitation in adopting these technologies. This apprehension can hinder market growth, as individuals may opt for alternative therapies or treatments that are perceived as carrying fewer risks, thereby impacting overall market demand and acceptance of bone growth stimulators.

Market Trends of the Global Bone Growth Stimulators Market

The Global Bone Growth Stimulators market is experiencing a significant shift driven by the growing preference for non-invasive treatment options. Patients and healthcare professionals are increasingly gravitating towards bone growth stimulators, which offer a more patient-friendly alternative to traditional surgical interventions for conditions such as spinal fusion and fractures. This trend reflects a broader demand for less intrusive methods that enhance healing and recovery while minimizing risks and discomfort. Additionally, advancements in technology and increased awareness of these devices' benefits are contributing to their rising adoption, positioning bone growth stimulators as a vital component of modern orthopedic care.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Bone Growth Stimulators Market Size by Material Type & CAGR (2026-2033)

Market Overview
Bone Growth Stimulation Devices
- External Bone Growth Stimulators
- Ultrasonic Bone Growth Stimulators
- Implanted Bone Growth Stimulators
Bone Morphogenetic Proteins
Platelet-Rich Plasma

Global Bone Growth Stimulators Market Size by Application & CAGR (2026-2033)

Market Overview
Spinal Fusion Surgeries
Delayed Union & Nonunion Bone Fractures
Oral & Maxillofacial Surgeries
Other Applications

Global Bone Growth Stimulators Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals and Ambulatory Surgical Centers
Home Care Settings
Academic and Research Institutes

Global Bone Growth Stimulators Market Size & CAGR (2026-2033)

North America (Material Type, Application, End User)
- US
- Canada
Europe (Material Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Material Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Material Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Material Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Orthofix Holdings, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioventus LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Igea S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ossatec AS (Norway)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DJO Global, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EMS Physio Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthocell Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Altis Biologics (South Africa)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ISTO Biologics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Regenlab SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Exactech, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Collagen Matrix, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ATEC, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments